Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
Hennekens
C H
CH
Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Buring
J E
JE
Sandercock
P
P
Collins
R
R
Peto
R
R
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D001696:Biomechanical Phenomena; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012008:Recurrence; D012307:Risk Factors
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin